early gastric cancer
Conditions
Interventions
in the abdomen.
In case gastrointestinal tract peristalsis is found scopolamine butylbromide 20mg intravenous administration.
Sponsors
Fukushima Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with early stage of gastric cancer (invasion depth T1) Patients whose overall condition is considered stable (no signs of infection within one week prior to operation and no steep deterioration of symptoms related to cancer, and medication is stable in amount and content) by their physicians in charge Patients who are able to communicate and able to understand the contents of the study
Exclusion criteria
Exclusion criteria: Patients who have history of partial gastrectomy Patients who has complication of uncontrolled diabetes or severe heart disease Patients who are not able to communicate due to severe mental disability or dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the peristaltic movement and ease of the operation using the Niwa Classification by physician who gives the endoscopic submucosal dissection | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the ease of the operation using VAS by physician Evaluation of the peristalsis inhibitory effect from video image | — |
Countries
Japan
Contacts
Public ContactMasao Suzuki
Aizu Medical Center, Fukushima Medical University Department of Kampo Medicine
Outcome results
None listed